Soon after WADA took action, the FDA added BPC-157 to the so-called Category 2 Bulk Substance List, which designates it as not eligible for compounding for human use
10.1016/j.cbi.2025.111459 73 LvR.LiuB.JiangZ.ZhouR.LiuX.LuT.et al (2025)
Ingredients Inactive Ingredients Vegetable glycerin, water, natural flavorings, fructose, and potassium sorbate
Available from: Karagiannis T, Bekiari E, Tsapas A (2023) Socioeconomic aspects of incretin-based therapy
Rather than waiting and hoping the skin catches up on its own, there is now substantial research suggesting that targeted peptide therapy can actively accelerate the skin remodeling process from the inside out
32 Limn-PachecoJ.GonsebattM